Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy.

Journal of internal medicine - 1 Oct 1992

Ericsson S, Eriksson M, Berglund L, Angelin B

Abstract excerpt

Ten male patients with familial combined hyperlipidaemia (FCHL) were studied with regard to LDL metabolism and composition. The FCHL patients had higher LDL levels than healthy controls (5.4 +/- 1.4 vs. 3.7 +/- 0.7 mmol l-1; P < 0.005) and a higher rate of production of the lipoprotein (15.8 +/- 3.1 mg kg-1 d-1 in FCHL vs. 13.1 +/- 1.8 mg kg-1 d-1 in the normals; P < 0.005). The fractional catabolic rate of LDL...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Apolipoproteins B

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholesterol, HDL

Share to Hyperlipidemia, Familial Combined

Share to Lipoproteins, LDL

Share to Phenotype

Share to Triglycerides

Source

Identifiers

PMID: 1402634
DOI: 10.1111/j.1365-2796.1992.tb00591.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy.PMID 1402634Read ↗

Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.Semantic proximity Read ↗

Postprandial lipaemia in familial combined hyperlipidaemia.Semantic proximity Read ↗

Low density lipoprotein kinetics in a family having defective low density lipoprotein receptors in which hypercholesterolemia is suppressed.Semantic proximity Read ↗

Plasma lipoproteins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia.Semantic proximity Read ↗

Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.Semantic proximity Read ↗

Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes.Semantic proximity Read ↗

Metabolic basis of primary hypercholesterolemia.Semantic proximity Read ↗

VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.Semantic proximity Read ↗

Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.Semantic proximity Read ↗

Cholesterol synthesis is increased in mixed hyperlipidaemia.Semantic proximity Read ↗

Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.Semantic proximity Read ↗

Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.